Saxenda Injection 6mg / ml

About Saxenda Injection 6mg / ml

Uses

• Chronic weight management in adults with a body mass index of 30 or above (obesity)
• Chronic weight management in adults with a body mass index of 27 or above who also have a weight related condition such as type 2 diabetes, high blood pressure, or high cholesterol
• Used together with a reduced calorie diet and increased physical activity, not as a standalone treatment

Benefits

• Supports gradual, sustained weight loss rather than rapid loss
• Reduces appetite and food cravings by acting on hunger centers in the brain
• Slows stomach emptying, helping patients feel full for longer after meals
• May improve blood sugar control and cardiometabolic markers alongside weight loss

What Experts Say

Liraglutide activates GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetite signals from the hypothalamus. This mechanism explains why weight loss with Saxenda tends to be gradual and sustained rather than rapid, since the drug works with the body's own satiety pathways instead of suppressing hunger artificially.

Physicians in Pakistan increasingly see Saxenda prescribed alongside diet and exercise counseling for patients with a body mass index of 30 or above, or 27 and above with a weight related condition such as type 2 diabetes or hypertension. The gradual weekly dose escalation schedule exists specifically to reduce nausea and vomiting, the most common reason patients discontinue GLP-1 therapy early.

Because of the thyroid C-cell tumor signal seen in rodent studies, doctors screen for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 before prescribing. Regular monitoring for pancreatitis symptoms and gallbladder complaints is also recommended for the duration of treatment, since both risks are clinically established with liraglutide.

Drug Class

• GLP-1 receptor agonist (glucagon-like peptide-1 receptor agonist)
• Anti-obesity / weight management agent

Saxenda Injection 6mg / ml formula

• Liraglutide 6mg/ml

Available forms

• Prefilled Pen Injection

How to use Saxenda Injection 6mg / ml?

• Inject once daily at any time of day, independent of meals, at approximately the same time each day
• Start at 0.6mg per day for one week
• Increase to 1.2mg per day in week 2
• Increase to 1.8mg per day in week 3
• Increase to 2.4mg per day in week 4
• Increase to the maintenance dose of 3mg per day from week 5 onward
• If a dose is not tolerated well, delay the next escalation step by an extra week before increasing further
• Inject subcutaneously into the abdomen, thigh, or upper arm, rotating injection sites with each dose
• Do not inject into a vein or muscle
• Use a new needle for every injection and dispose of used needles in a puncture proof container
• If a dose is missed by more than 12 hours, skip it and resume the regular schedule the next day, do not double up

Drug Interactions

• Increases the risk of low blood sugar when used with insulin or sulfonylureas such as glimepiride or gliclazide
• May reduce and delay absorption of oral medicines due to slowed gastric emptying, affecting drugs with a narrow therapeutic window
• Should not be combined with other GLP-1 receptor agonists such as semaglutide or dulaglutide
• Warfarin and other blood thinners may need closer monitoring since absorption timing can shift
• Oral contraceptives may have altered absorption, discuss backup contraception with a doctor
• Alcohol may increase the risk of low blood sugar and worsen gastrointestinal side effects

Risks and warnings

• Carries a boxed warning for thyroid C-cell tumors observed in rodent studies, the human relevance is not fully established
• Contraindicated in patients with a personal or family history of medullary thyroid carcinoma
• Contraindicated in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Not recommended for anyone with a history of pancreatitis, since liraglutide has been linked to acute pancreatitis
• Can increase the risk of gallbladder disease, including gallstones and cholecystitis
• Not approved for use in type 1 diabetes or diabetic ketoacidosis
• Should not be combined with insulin or other GLP-1 receptor agonist medicines
• Not for use during pregnancy or breastfeeding
• May increase heart rate, monitor patients with existing cardiovascular disease
• Use with caution in patients with kidney or liver impairment
• Stop treatment and seek medical care immediately if symptoms of pancreatitis, gallbladder disease, or a thyroid lump or neck swelling develop

Saxenda Injection 6mg / ml Side Effects

• Nausea, especially during the first weeks of treatment or after a dose increase
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain or discomfort
• Decreased appetite
• Headache
• Fatigue
• Dizziness
• Injection site reactions such as redness or itching
• Low blood sugar, particularly when combined with other diabetes medicines
• Rare but serious reactions including pancreatitis, gallbladder disease, and allergic reactions

Storage Conditions

• Store unopened pens in a refrigerator between 2°C and 8°C
• Do not freeze, and discard the pen if it has been frozen
• Once a pen is in use, it can be stored either in the refrigerator or at room temperature below 30°C
• An in-use pen must be discarded 1 month after first use, even if some medicine remains
• Always keep the pen cap on when not in use to protect it from light
• Keep away from direct heat and sunlight
• Keep out of reach of children